"Holli Baumunk took over as president and CEO of the Colorado BioScience Association (CBSA) on July 12. She already
was familiar with the state’s biotech drug and medical device companies from working as vice president of the Metro
Denver Economic Development Corp.
A top priority of her first year will be working on creating a “fund of
funds,” designed to supply capital to private venture funds investing in startup companies that commercialize Colorado
technologies in the biotech drug, medical device, biofuel and clean technology fields. An industry road map prepared for the
CBSA in 2008 recommended pushing for a $250 million “fund of funds” similar to ones in other states that use money
from state employee pension funds and other investors."Link to Greg Avery's profile of Holli Baumunk in today's DBJ
"The Boettcher Foundation today awarded six biomedical researchers from Colorado universities three-year grants of up
to $250,000 each.
All six are in early stages of their careers, a time when it is difficult for researchers to
get the grants needed to fund scientific work.
The Webb-Waring Biomedical Research Program grants are an investment
in science that has the potential to make significant contributions to human health, said Timothy W. Schultz, president of
the Boettcher Foundation."Link to the Denver Post